Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria

Autor: Smaili, F, Boudjella, A, Dib, A, Braikia, S, Zidane, H, Reggad, R, Bendib, A, Abdelouahab, A, Bereksi-Reguig, F, Yekrou, D, Bentouati, A, Filali, T, Chirouf, A, Djehal, N, Mahfouf, H, Mechiat, F, Tadjerouni, H, Sedkaoui, C, Hikem, M, Amber, A, Bouzid, K, Ladjeroud, A, Ghomari, S, Aris, H, Saidi, S, Larhbali, R, Saidi, MA, Haddouche, A, Kedar, M, Bounedjar, A, Talha, S, Benbrahim, W, Ammari, A, Boushaba, A, Rabah, A, Ameziane, N, Benabdallah, F, Djedi, H, Kouadri, N, Bensalem, A, Djeghim, S, Oukkal, M, Hadjam, F, Larbaoui, B, Rekai, K, Azzouz, N, Badaoui, A, Abid, M, Abada, M, Moussei, A, Benmehidi, F, Benzidane, N, Boualga, K, Mesli, S

Publikováno v: In Cancer Treatment and Research Communications 2020 25

ORY-1001, a KDM1A inhibitor, inhibits proliferation, and promotes apoptosis of triple negative breast cancer cells by inactivating androgen receptor.

Autor: Wang T; Department of Oncology and Hematology, Yan'an People's Hospital, Yan'an City, Shaanxi Province, China., Zhang F; Department of Oncology and Hematology, Yan'an People's Hospital, Yan'an City, Shaanxi Province, China., Sun F; Department of Thyroid and Breast Surgery, The Second People's Hospital of Nantong, Nantong City, Jiangsu Province, China.

Publikováno v: Drug development research [Drug Dev Res] 2022 Feb; Vol. 83 (1), pp. 208-216. Date of Electronic Publication: 2021 Aug 04.